Mapping patterns of locoregional recurrence following contemporary treatment with radiation therapy for breast cancer: A multi-institutional validation study of the ESTRO consensus guideline on clinical target volume

2018 ◽  
Vol 126 (1) ◽  
pp. 139-147 ◽  
Author(s):  
Jee Suk Chang ◽  
Jeongshim Lee ◽  
Mison Chun ◽  
Kyung Hwan Shin ◽  
Won Park ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Radiation Therapy ◽  
Validation Study ◽  
Locoregional Recurrence ◽  
Clinical Target Volume ◽  
Target Volume ◽  
Consensus Guideline

scholarly journals Radiation-Induced Toxicity Risks in Photon Versus Proton Therapy for Synchronous Bilateral Breast Cancer

2021 ◽  
Author(s):  
Line Bjerregaard Stick ◽  
Maria Fuglsang Jensen ◽  
Søren M. Bentzen ◽  
Claus Kamby ◽  
Anni Young Lundgaard ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lung Cancer ◽  
Radiation Therapy ◽  
Coronary Artery ◽  
Early Breast Cancer ◽  
Proton Therapy ◽  
Clinical Target Volume ◽  
Target Volume ◽  
Radiation Dermatitis ◽  
Radiation Induced

Abstract Purpose This study compares photon and proton therapy plans for patients with synchronous bilateral early breast cancer and estimates risks of early and late radiation-induced toxicities. Materials and Methods Twenty-four patients with synchronous bilateral early breast cancer receiving adjuvant radiation therapy using photons, 3-dimensional conformal radiation therapy or volumetric modulated arc therapy, were included and competing pencil beam scanning proton therapy plans were created. Risks of dermatitis, pneumonitis, acute esophageal toxicity, lung and breast fibrosis, hypothyroidism, secondary lung and esophageal cancer and coronary artery events were estimated using published dose-response relationships and normal tissue complication probability (NTCP) models. Results The primary clinical target volume V95% and/or nodal clinical target volume V90% were less than 95% in 17 photon therapy plans and none of the proton plans. Median NTCP of radiation dermatitis ≥ grade 2 was 18.3% (range, 5.4-41.7) with photon therapy and 58.4% (range, 31.4-69.7) with proton therapy. Median excess absolute risk (EAR) of secondary lung cancer at age 80 for current and former smokers was 4.8% (range, 0.0-17.0) using photons and 2.7% (range, 0.0-13.6) using protons. Median EAR of coronary event at age 80, assuming all patients have preexisting cardiac risk factors, was 1.0% (range, 0.0-5.6) with photons and 0.2% (range, 0.0-1.3) with protons. Conclusion Proton therapy plans improved target coverage and reduced risk of coronary artery event and secondary lung cancer while increasing the risk of radiation dermatitis.

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer, version 1.1

2016 ◽  
Vol 118 (1) ◽  
pp. 205-208 ◽  
Author(s):  
Birgitte V. Offersen ◽  
Liesbeth J. Boersma ◽  
Carine Kirkove ◽  
Sandra Hol ◽  
Marianne C. Aznar ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Radiation Therapy ◽  
Early Stage ◽  
Target Volume ◽  
Early Stage Breast Cancer ◽  
Consensus Guideline ◽  
Target Volume Delineation ◽  
Volume Delineation

ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer

2015 ◽  
Vol 114 (1) ◽  
pp. 3-10 ◽  
Author(s):  
Birgitte V. Offersen ◽  
Liesbeth J. Boersma ◽  
Carine Kirkove ◽  
Sandra Hol ◽  
Marianne C. Aznar ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Radiation Therapy ◽  
Early Stage ◽  
Target Volume ◽  
Early Stage Breast Cancer ◽  
Consensus Guideline ◽  
Target Volume Delineation ◽  
Volume Delineation
Sign in / Sign up

Export Citation Format

Share Document